![Henry Ji](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henry Ji
Chief Executive Officer at SORRENTO THERAPEUTICS, INC.
Net worth: 803 048 $ as of 31/05/2024
Henry Ji active positions
Companies | Position | Start | End |
---|---|---|---|
SORRENTO THERAPEUTICS, INC. | Chief Executive Officer | 01/04/2011 | - |
Chairman | 01/08/2017 | - | |
Founder | 01/01/1989 | - | |
President | 01/09/2012 | - | |
Director/Board Member | 01/01/2006 | 01/08/2017 | |
Chief Tech/Sci/R&D Officer | 01/11/2008 | 01/09/2012 | |
Corporate Secretary | 01/09/2009 | 01/06/2011 | |
SCILEX HOLDING COMPANY | Chairman | 09/11/2022 | - |
SCILEX Pharmaceuticals, Inc.
![]() SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Director/Board Member | 01/11/2016 | - |
Chief Executive Officer | 01/11/2016 | 01/03/2019 | |
Scintilla Pharmaceuticals, Inc.
![]() Scintilla Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Scintilla Pharmaceuticals, Inc. develops and commercializes pharmaceutical products. It offers RTX, a program for the treatment of opiate refractory cancer pain. The company is headquartered in San Diego, CA. | Chief Executive Officer | - | - |
Director of Finance/CFO | - | - | |
BioVintage, Inc.
![]() BioVintage, Inc. Miscellaneous Commercial ServicesCommercial Services BioVintage, Inc. provides research and development services. It focuses on life science technology and product development. The company was founded by Henry Ji on October 10, 2002 and is headquartered in San Diego, CA. | Founder | 01/01/2002 | - |
President | 01/01/2002 | - | |
Elsie Biotechnologies Inc.
![]() Elsie Biotechnologies Inc. BiotechnologyHealth Technology Part of GSK Plc, Elsie Biotechnologies Inc. is a private biopharmaceutical company dedicated to unlocking the full potential of oligonucleotide therapeutics. The company is based in San Diego, CA. Elsie Biotechnologies integrates discovery, development, and delivery to increase potency, decrease toxicity, and optimize delivery of oligonucleotide therapeutics. The company's platform accesses the entire oligonucleotide chemistry space to optimize gene silencing and splice switching, and develops novel oligonucleotide therapeutics that are more potent, safer, and easier to deliver to target tissues. Elsie Biotechnologies is focused on unlocking the full potential of RNA therapeutics to treat undruggable diseases. The company was founded in 2021 by Phil Baran and Philip E. Dawson. The CEO is Kevin Green. Elsie Biotechnologies was acquired by GSK Plc on June 06, 2024 for $50 million. | Director/Board Member | - | - |
Career history of Henry Ji
Former positions of Henry Ji
Companies | Position | Start | End |
---|---|---|---|
Scilex, Inc.
![]() Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Chairman | 01/03/2019 | 01/11/2022 |
Celularity, Inc. (United States)
![]() Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Director/Board Member | 01/06/2017 | 01/07/2021 |
IMMUNITYBIO, INC. | Director/Board Member | 29/12/2014 | 25/11/2015 |
░░░░░░ ░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Henry Ji
University of Minnesota | Doctorate Degree |
Fudan University | Undergraduate Degree |
Statistics
International
United States | 17 |
China | 2 |
Operational
Director/Board Member | 7 |
Chief Executive Officer | 4 |
Founder | 4 |
Sectoral
Health Technology | 10 |
Consumer Services | 3 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
SORRENTO THERAPEUTICS, INC. | Health Technology |
SCILEX HOLDING COMPANY | Health Technology |
Private companies | 13 |
---|---|
CombiMatrix Corp.
![]() CombiMatrix Corp. BiotechnologyHealth Technology CombiMatrix Corp. engages in the provision of clinical diagnostic services. It offers cytogenomic testing for preimplantation genetic testing, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company was founded in October 1995 and is headquartered in Irvine, CA. | Health Technology |
NantKwest, Inc.
![]() NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
Quikbyte Software, Inc.
![]() Quikbyte Software, Inc. Financial ConglomeratesFinance The Company is develops and markets Computere Software.The Company was Founded in 1989 and it's Headquartered is in Miami,FL. | Finance |
SCILEX Pharmaceuticals, Inc.
![]() SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
Stratagene Corp.
![]() Stratagene Corp. Medical SpecialtiesHealth Technology Stratagene Corp. researches, develops and markets diagnostic products and technologies for life science research. The company's products are used in the research of amplification, cell biology, cloning, microarrays, nucleic acid analysis, protein function and analysis, and quantitative PCR. Its clients include the industrial and government research sectors. The firm sells its products in more than 60 countries. Stratagene was founded in 1984 and is located in La Jolla, CA. | Health Technology |
Sorrento Therapeutics, Inc. /Old/
![]() Sorrento Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Sorrento Therapeutics, Inc. develops human monoclonal antibodies based on its proprietary technology for research, diagnostic and therapeutic use. The company is headquartered in San Diego, CA. | Health Technology |
BioVintage, Inc.
![]() BioVintage, Inc. Miscellaneous Commercial ServicesCommercial Services BioVintage, Inc. provides research and development services. It focuses on life science technology and product development. The company was founded by Henry Ji on October 10, 2002 and is headquartered in San Diego, CA. | Commercial Services |
Stratagene Genomics, Inc. | |
Hongye SD Group LLC | |
Scintilla Pharmaceuticals, Inc.
![]() Scintilla Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Scintilla Pharmaceuticals, Inc. develops and commercializes pharmaceutical products. It offers RTX, a program for the treatment of opiate refractory cancer pain. The company is headquartered in San Diego, CA. | Retail Trade |
Celularity, Inc. (United States)
![]() Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Commercial Services |
Scilex, Inc.
![]() Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Health Technology |
Elsie Biotechnologies Inc.
![]() Elsie Biotechnologies Inc. BiotechnologyHealth Technology Part of GSK Plc, Elsie Biotechnologies Inc. is a private biopharmaceutical company dedicated to unlocking the full potential of oligonucleotide therapeutics. The company is based in San Diego, CA. Elsie Biotechnologies integrates discovery, development, and delivery to increase potency, decrease toxicity, and optimize delivery of oligonucleotide therapeutics. The company's platform accesses the entire oligonucleotide chemistry space to optimize gene silencing and splice switching, and develops novel oligonucleotide therapeutics that are more potent, safer, and easier to deliver to target tissues. Elsie Biotechnologies is focused on unlocking the full potential of RNA therapeutics to treat undruggable diseases. The company was founded in 2021 by Phil Baran and Philip E. Dawson. The CEO is Kevin Green. Elsie Biotechnologies was acquired by GSK Plc on June 06, 2024 for $50 million. | Health Technology |
- Stock Market
- Insiders
- Henry Ji
- Experience